Human natural killer (NK) cell differentiation from immature lineage negative (Lin-) umbilical cord blood cells was examined in vitro. Cells expressing differentiation antigens of mature NK cells (CD56, CD16, CD2, CD8, NKR-P1A) were generated from Lin-cells cultured with mterleukin (IL)-2 and a murine bone marrow stromal cell line expressing the human membranebound form of stem cell factor. Two subsets of NK cells were identified in these cultures: one expressed both NKtL-P1A and CD56 and, in variable proportions, all other NK cell differentiation antigens; the second subset expressed only NKR-P1A and, unlike the former, was not cytotoxic. Neither subset expressed interferon (IFN)-y mtLNA even after stimulation with phorbol di-ester and Ca 2+ ionophore, but both expressed tumor necrosis factor ot mRNA and the cytotoxic granule-associated proteins TIA-1, perforin, and serine esterase-1. After 10-d culture with IL-2, IL-12, and irradiated B lymphoblastoid cells, ~45% of the NKR.-PIA+/ CD56-cells became CD56 +, and the same cultures contained cells capable ofcytotoxicity and of IFN-y production. These results indicate that NKR.-P1A expression in the absence of other NK cell markers defines an intermediate, functionally immature stage of NK cell differentiation, and that effector functions develop in these cells, concomitantly with CD56 expression, in the presence of IL-12. These cells likely represent the counterpart of a CD3-/NKR-P1A+/ CD56 /CD16-cell subset that, as shown here, is present both in adult and neonatal circulating lymphocytes.
N
K cells are a lymphocyte subset distinct from B and T cells, lacking expression of the antigen-specific receptors present on these cell types (T and B cell receptors, i.e., TCP,. and slg/BCl<) (reviewed in reference 1). They represent -~15% of the circulating lymphocytes in adult and neonatal peripheral blood (2) , are effectors of nonadaptive immunity, are cytotoxic, in the absence of known presensitization, to a variety of target cells, and, via IFN-y production, they facilitate the development of Th0 to Thl cells (3), thus promoting cell-mediated immune responses (4) . No unique NK cell marker has been identified yet, but expression of a set of differentiation antigens in the absence of antigen-specific receptors ofT and B lymphocytes serves to identify these cells. CD16 and CD56 are expressed, either alone or in combination, on the majority of mature NK cells (2) . Other antigens expressed on subsets of NK cells include CD8 (30-50%) (5) , and CD2 (50-70% of NK cells from umbilical cord blood and >90% of NK cells from adult blood) (2) .
Human NK cell progenitors exist in the lineage negative (Lin-)l/CD34 + subset of hematopoietic cells that includes mulfilineage progenitors and hematopoietic stem cells (6) (7) (8) (9) (10) . A variety of in vitro culture conditions, requiring IL-2, IL-15, and/or bone marrow stromal cells (7, 8) or stem cell factor (SCF) (9, 10), or IL-15 (11) support differentiation of these cells to mature CD56 + cytotoxic NK cells. CD7 is expressed on early NK cell progenitors; these have growth factor requirements distinct from those of more differentiated cells: CD7+/CD34 + NK cell progenitors require bone marrow stromal cells and IL-2 to differentiate into CD56 + cytotoxic cells (7) , while CD7+/CD34-/CD56 -cells, representing more mature progenitor cells in umbilical cord blood, require only IL-2 (12) . In the murine system, NK cells at distinct stages of differentiation have been identified based on surface phenotype; non-stem cell hematopoietic 1Abbrewations used in this paper" ADCC, antibody-dependent cell-me&ated cell to:rdclty; GaMIg, goat anti-mouse Ig; Lm-, hneage negative; MSE, monocyte-specific esterase; tLT, reverse transcripnon, SCF, stem cell factor; SE, senne esterase progenitors lacking expression of mature NK cell surface antigens develop into mature cytotoxic NK cells in adoptive transfer experiments (13, 14) . Conjugate-forming, noncytotoxic, putative pre-NK cells that express NKR-P1C (NKI.1) in the absence of other mature NK cell markers have been identified in mice in which, after bone marrow ablation, NK cell differentiation is incomplete (15) . Differentiation antigens that identify human NK cells at intermediate stages of differentiation at which they have unequivocal, although possibly incomplete, NK cell phenotype, and at which they are functionally immature have not been described. In addition, the specific sequence with whxch human NK cells acquire differentiation antigens and/or functions, and the growth factors supporting NK cell development/differentiataon have been determined only in part. Here we report the identification of a functionally immature, noncytotoxic NK cell subset, characterized by the expression of NKR-P1A and lack of other NK cell differentiation antigens, that can be induced to differentiate to functionally and phenotypically mature NK cells in the presence oflL-12. A subset of adult and neonatal circulating NK cells was also identified, that has a surface phenotype similar, if not identical, to that of the immature NK cells generated in vitro.
Materials and Methods
Monodonal and Polydonal Antibodies. Most (2) , of the P3x63-Ag8.653 nonsecretor myeloma cells with splenocytes from a BALB/c mouse immunized (three times lntraperitoneally at weekly intervals, and once intravenously 3 d before fusion) with purified human NK cells, prepared as described previously (16) and cultured for 3 d with IL-2. This mAb (IgG2b, as determined by xmmunodiffuslon with lSOtypespecific antibodies) detects NKR-P1A on NK cells and subsets of CD4 + and CD8 + T cells (not shown), as indicated by the observauons that: (a) it immunoprecipitates from mature NK cells an 80-kD surface molecule, a disulfide-linked homodimer of two 40-kD chains (Zatsepina, O., and B. Perussxa, unpubhshed data); (b) it cross-competes with the anti-NKR-PIA mAb DX-1 (21) for binding to NK cells; and (c) it reacts with NKR-PIA-transfected, but not untransfected, murme L cells (assay kindly performed by Dr. L. Lanier, DNAX, Palo Alto, CA). When indicated, this and other rnAbs were labeled with biotin or FITC according to standard procedures, after purification from ascltes on protein G-Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) columns.
The polyclonal goat anti-mouse Ig (GaMIg) used for panning was produced in our laboratory, adsorbed on human Ig and affinity-purified on mouse tg-Sepharose before use (16) . The rabbit IgG anti-sheep erythrocyte used to prepare immune complex monolayers was from Cappel (Durham, NC).
Cell Isolation. Umbilical cord blood, collected at delivery and anticoagulated with heparin, was kindly provided by Dr. tL. Depp (Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital, Philadelphia, PA). PBMC were isolated on Facoll/Hypaque density gradient (Histopaque-1077; Sigma Chemical Co., St. Louis, MO) and contaminating erythrocytes were lysed using NH4C1 buffer (0.15 M NH4C1, 0.01 M KHCO3, 0.1 mM EDTA; 4°C, 10 min). PBL were isolated from PBMC after adherence to plastic (37°C, 20 mln). The majority of T and NK cells were depleted after rosettmg with 2-ammoethylisothlouromum bromide (hydrdorormde) (Sigma Chemical Co.)-treated sheep E (21). PBL not forming E-rosettes were collected at the interface of Ficoll/Hypaque density gradients and Fc~/R + (NK, B, and myelo-monocytic) cells were depleted after incubation on rabbit IgG immune complex monolayers as described (22). Residual mature hematopoietic cells were depleted from the Fc~/tLcells by indirect anti-Ig panning (23) (30 min, 4°C) on GaMIgtreated polystyrene petri dishes after sensitization with a panel of mAbs to differentiauon antigens on mature hematopoietlc cells, including mAb (clones listed above) to CD2, CD3, CD4, CD5, CD8, CD11b, CD14, CD15, CD21, CD56, CD94, and NKtL-PIA. The procedure was repeated three times to maxan~ze depletion. These populations, referred to as Lin-cells, were >99% CD3-/CD56-/NKIL-P1A-/CD16 ; the malonty of them (81.2 + 9.7%, n = 9) were HLA-DR + and contained 57.6 + 19.7% (n = 7) CD34 + cells, as determined by indirect immunofluorescence.
When indicated, resting NK cells were prepared from adult and umbilical cord blood PBL after sensitization with a rmxture of mAb to CD3, CD4, CD5, CD14, CD15, CD21, and CD34 and panning. The resulting cell populations contained 81.1 + 5.8% NKR-P1A + and 1.8 + 0.6% CD3 + cells (n = 7), as tested in indirect lmmunofluorescence; CD3+/NKR-P1A + cells were undetectable. Homogeneous NK cell populations were also punfied from 10-d cultures of umbilical cord blood PBL with the B-lymphoblastoid tLPMI 8866 cell line (16) .
NKR-P1A~/CD56 + and NKR-P1A+/CD56 -cells were purified from day-30 cultures of Lin-cells (see below) by indirect anti-Ig panning. For this, CD56 + cells were selected (procedure repeated twice) after sensitization with anti-CD56 mAb. Homogeneous NKR-P1A+/CD56 -populations were then prepared from the CD56 cells after sensitization with B199.2. The cell populauom obtained were >99% NKR-P1A+/CD56 -' and NKR-P1A+/ CD56 +, respectively, as determined by indirect lmmunofluorescence.
Hematopoietic Progenitor Cell Cultures. Lin-cells were cultured (37°C, 8% CO 2 atmosphere) in 24-well ussue culture plates (2 X 105 cells/well) m 2 ml RPMI 1640 medium (BioWhittaker Inc., Walkerswlle, MD) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Sigma Chemical Co.) on a confluent monolayer of 30-Gy irradiated murine S1/S14 bone marrow stromal cell hne or its denvative S1/SPhSCF 22°, expressing membrane-bound SCF (24) (provided by Dr. D. Williams, University of Indiana School of Medicine, Indianapolis, IN). Recombinant (r) IL-2 (50 U/ml, sp act 1.1 × 106 U/rag protein, obtained from the Biological Response Modifiers Program, National Cancer Institute, Bethesda, MD) was added at the beginning of the cultures and every 4 d during a 30-d culture penod. The culture medium was partially replaced every 7 d, and nonadherent cells from mdiwdual wells were subcultured when confluent (once or twice, on average). These culture conditions are referred to as "primary cultures."
For secondary cultures, 106 NKR-PIA+/CD56 + and CD56 cells, separated as described above from day-30 primary cultures, were cultured for 10 d in 2 ml medmm/well of 24-well culture plates, rlL-2 (50 U/ml) and rlL-12 (1 ng/ml, sp act 4.5 × 106 U/mg protein in an IFN-'y induction assay; kindly provided by Dr. S. Wolf, Genetics Institute, Andover, MA) were added at the beginning of the culture and every 4 d afterward. Daudi cells (30-Gy irradiated) were added (2 × 105 cells/well).
Immunofluorescence (Flow Cytometry).
One-, two-, and threecolor lmmunofluorescence analysis was performed with the indicated FITC-, PE-, or biotin-labeled mAb as previously described (2, 16) . FITC-(Vector Laboratories, Burhngame, CA), PE-(Becton Dickinson and Co.), or P,.670-(Gibco BR.L, Gaithersburg, MD) labeled streptavidin were used to detect biotin-labeled mAb. Samples were analyzed on an EPICS Elite, or a Profile-II flow cytometer (Coulter Corp.).
Cell-mediated Cytotoxicity. This was tested in 4-h 51Cr release assays using K562 or P815 cells sensitized with anti-P815 rabbit serum as targets for spontaneous and antibody-dependent cellmediated cytotoxicity (ADCC), respecnvely (2) . Target cells were 104/well. When indicated, effector cells were incubated (5 × 106 cells/ml 18 h, 37°C) with rlL-2 (50 U/ml) and rlL-12 (4 ng/ml) before testing.
Reverse Transcription (RT) PCR. Cells were incubated (5 × 106 cells/ml, 2 h, 37°C) or not, as indicated, in medium without or with PMA (10 -9 M; Sigma Chemical Co.) and Ca 2+ ionophore (A23187, 0.1 I~g/ml; Sigma Chemical Co.). Total R.NA was extracted from 2.5 × 105 cells using RNAzol (Biotecx Laboratories, Houston, TX) after the manufacturer's protocol, mRNA was reverse-transcribed using Moloney murine leukemia virus reverse transcnptase and ohgo-dT 3' primer (37°C, 1 h). The primer pairs were designed to span lntronic regions, to prevent genomxc DNA amplification. CD16 cDNA was amphfied (30 cycles) using previously described oligonucleotide primers and conditlons (25). Primers (synthesized at the Kimmel Cancer Center Nucleic Acid Facility) were: No. 616: sense GGG GGC TTG TTG GGA GTA AA; No. 485: antlsense GAG AGG CCT GAG GAT GAT. The 13 actin primers were derived from the murine sequence (sense TGG GAA TGG GTC AGA AGG ACT; antisense TTT CAC GGT TGG CCT TAG GGT T) (30 amphficatlon cycles: melting, 94°C; annealing, 55°C; extension, 72°C; 1 rain each). IFN-~/ (sense GCA TCG TTT TGG GTT CTC TTG GCT GTT ACT GC; antisense CTC CTT TTT CGC TTC CCT GTT TTA GCT GCT GG), and TNF-oL (sense GAG TGA CAA GCC TGT AGC CCA TGT TGT AGC A; antxsense GCA ATG ATC CCA AAG TAG ACC TGC CCA GAC) primers were purchased from Clontech Laboratories, Inc. (Palo Alto, CA) (30 cycles: melting, 1 nun, 94aC; annealing, 1 rain, 60°C; extension, 2 min, 72°C). Monocyte-specific esterase (MSE) cDNA was amplified using previously described oligonucleotide primers (sense GGC AGT TAC TCT CAG AGG CTA; antisenseq2TT CCA CAG GAG TGA CAT GGC) and conditions (26). PCR products were electrophorese~! in 2% agarose gels and, when indicated, transferred to nylon membrane 
IFN-T and TNF-a RIA.
These were performed as previously described (28, 29) on the cell-free supernatants from cells cultured for the times specified in the indicated conditions, using the mAb pairs B133.1, B133. Immunocytochemistry. Cells (3 X 104) were cytocentrifuged on poly-L-lysine-treated slides, fixed in acetone (-20°C, 10 rmn), and stored at -80°C until use. mAb to TIA-1 (30) (IgG, 5 Ixg/ml; Coulter Corp.) and to tL-12 p40 (31) (C8.1, ascites, 10 -3 dilution; provided by Dr. G. Tnnchien, Wistar Institute, Philadelphia, PA), rabbit anti-mouse perforin antiserum cross-reacting with human perforin (32) (provided by Dr. C.-C. Era, The Rockefeller University, New York) or control nonimmune rabbit serum (both 10 -2 dilution) were added to the rehydrated cells. After incubation and washings, positive cells were detected with biotin-labeled GaMIg or goat anti-rabbit Ig and biotm-labeled horseradish peroxidase-avidm complex (ABC kit; Vector Laboratories, Burhngame, CA) and diaminobenzidine (Sigma Chemical Co.) substrate, following the manufacturer's instructions. Staimng was intensified using the diaminobenztdme intens~ficatlon reagent (Vector Laboratories), and hematoxylin was used to counterstain the nuclei. Single-cell NoL-benzyloxycarbonyl-L-lysine-thiobenzyl ester, hydrochloride esterase assays to detect senne esterase (SE)-I were performed, according to pubhshed procedures (33), on cytocentrifuge preparations of NKR-P1A+/CD56 + or CD56-cells prepared as described above from 30-d cultures.
Statistical Analysis. Data were analyzed using the two-tailed, two-sample t test (Minitab statistical analysis software; State College, PA). P <0.05 were considered significant.
Results

Identification of a CD3 /NKR-PIA +/CD56-/CD16-Lymphocyte Population within Adult and Umbilical Cord Blood. As in
PBL from adults (34, and data not shown), CD3-/CD56 + and CD3-/CD16 ÷ NK cell subsets were detected in umbilical cord blood PBL. The majority (>70%) of the CD16 + cells expressed CD56, and >90% of the CD56 + cells expressed CD16, as determined by two-color immunofluorescence (flow cytometry) (Fig. 1, top) . was expressed on all CD16 + and CD56 + NK cells, therefore identifying most, if not all, neonatal NK cells, and on 25% of the CD3 + T lymphocytes (Fig. 1, bottom) . (Fig. 3 A) , C D 1 6 +, or N K R -P 1 A + cells (not shown), as tested by indirect i mmunofluorescence. T h e y did not mediate spontaneous cytotoxicity or A D C C even after 18-h incubation with IL-2 and IL-12 ( Fig. 3 B) and did not contain cells expressing C D 1 6 mR.NA, as detected using R T -P C P , (Fig. 3 C) with sensitivity to detect 1 in 5 × 105 C D 1 6 + cells (not shown).
Several culture conditions (Table 1) were analyzed for their ability to support N K cells' generation from the L i npopulations a n d / o r mature N K cells survival/proliferation. PBL from umbilical cord blood, and C D 3 -/ N K I < -P 1 A + N K cells purified from them, did not proliferate w h e n cultured with S1/S14hSCF 22° and IL-2, and the latter died within 14 d. Fig. 4 ). Starting at nearly day 20, their numbers increased until day 39, the last time point examined, as shown in the same figure (the total numbers of C D 3 -/ N K R -P 1 A + cells/well were 2.7 + 0.9 X 10 s , n = 5, and 2.1 + 1.0 × 106 , n = 4 , in 1 6 -2 5 -and 2 6 -3 9 -d cultures, m e a n + SD).
After 20 d, two C D 3 -/ N K R -P I A + N K cell populations were detected in the cultures: one (40.2 + 21.5%, m e a n + SD, n = 9) was C D 5 6 +, the other (57.9 -+-23.2%) was C D 5 6 - (Fig. 5, top) . (Fig. 5, bottom) . C D 7 and cytoplasmic CD3~ were detected in most cells in both subsets (data n o t shown). (Fig. 6 A) . The CD56 ÷, but not the CD56-, subset purified from them was cytotoxic against the same target cells (Fig. 6 A) . The granule-associated protein TIA-1 was expressed in 90.0 + 3.0% of the CD56 ÷ cells (mean + SD, n = 3), as tested by immunocytochemistry ( Fig. 6 B) ; the same protein was detected in 64.0 + 15.0% of the CD56-cells. Cells expressing SE-1 and perforin were detected in each subset in proportions similar to those seen for TIA-1 (data not shown).
Cytotoxic Activity of NKR-PIA +/CD56-N K Cells. The
Induction of NKR-PIA+ /CD56 -NK Cells' Differentiation.
To test the hypothesis that the NKR.-P1A+/CD56 cells were immature NK cells with potential to differentiate further, homogeneous populations of these cells were purified from day-30 cultures, and were cultured for 10 additional days in the conditions listed in Table 2 . Cell viability was maintained in all conditions, but a significant proportion of CD56 + cells (43.2 + 25.9%, mean + SD, n = 7) was detected only in cultures with irradiated Daudi cells, IL-2, and IL-12 (P <0.05) and the cells from these cultures, like those from cultures of the CD56 + subset (not shown) were cytotoxic to K562 target cells (Fig. 7) . NKK-P1A expression and viability of the CD56 + subset were maintained throughout secondary culture in each of the culture conditions (data not shown). As shown in Fig. 8 , NKR-P1A+/CD56 -cells from 30-d cultures expressed no detectable IFN-y mKNA even after stimulation with phorbol diester and Ca 2+ ionophore. Instead, IFN-',/mR.NA was detected in the same populations after 10-d secondary culture. Both CD56 ÷ (not shown) and CD56-/NKR-P1A + cells (Fig. 8) expressed TNF-oL mRNA constitutively both before and after secondary culture. Minimal amounts of IFN-',/and TNF-ci were present in the supernatants from primary cultures (up to day 30); instead, both cytokines were detected at significant levels in cell-free supernatants collected during secondary culture (Table 3) .
Discussion
In this study, we identify a discrete subset of immature NKK-P1A+/CD56 human NK cells and its requirements for differentiation to phenotypically mature CD56 + NK cells capable ofcytotoxicity and IFN-~/production. NK cells were generated in cultures containing SCF and IL-2. Because mature NK cells could not be generated in the absence of SCF, both cytokines are necessary for this process. Shibuya et al. (9) proposed that, in the presence of SCF, CD34 + early NK cell progenitors in the bone marrow are sequentially sensitive to 1L-3 and IL-2, and become sensitive to IL-2 and SCF independent only after they reach the stage of differentiation at which they express CD122 and CD56. Our data support a minimal require- These data also indicate that the proliferation/maturation requirements of mature and immature NK cells are distinct. Unlike previous reports, we detected two distinct NKR-P1A + NK cell populations in the cultures. Similar to NK cells derived in other culture conditions (6, 8, 10, 12) , one subset is phenotypically and functionally mature and expresses CD56 and, although only on a minor proportion of the cells, other surface antigens of mature NK cells, e.g., CD16, CD2, and CD8. It is possible that CD16 represents a late NK cell differentiation antigen, as is the case for myeloid cells (37) , that the culture conditions provided do not allow complete phenotypic maturation, and/or that cytokines inducing CD16 expression, e.g., platelet-derived growth factor (38) , are missing.
The second subset, NKR-P1A+/CD56 -, is functionally and phenotypically immature and has a surface phenotype similar, if not identical, to that of the NKR-P1A+/ CD56 /CD16-subset we have identified in both adult and neonatal PBL. The existence of circulating immature NK cells had been postulated by Nagler et al. (34) , who described a CD56+/CD16 -PBL subset that, unlike mature NK cells, expresses IL-2Ro~, once stimulated with IL-2 proliferates in response to IL-4, and does not express IFN-~/ mRNA. Being CD56 and not cytotoxic, the CD16 / NKR-PIA + cells described here are distinct from that population. Given the limited number of circulating NKR-P1A+/CD16-/CD56 -cells, no functional data are available yet for these cells isolated directly from PBL; however, A.
B.
2S. based on the in vitro data, it can be hypothesized that these cells represent circulating immature N K cells that can be recruited to functional maturation. Several possibilities may explain the presence in our cultures of both mature N K cells and those in an apparently arrested state of development. Lin populations are heterogeneous and may contain N K cell progenitors at different stages of differentiation and with distinct growth factor requirements. The most mature ones, as previously proposed (9, 12) , may respond readily to IL-2, a n d / o r be induced to differentiate by factors endogenously produced or added exogenously. More immature progenitors may need additional factors that are not provided or produced in the cultures. Alternatively, a n d / o r in addition, the culture conditions likely change during the course o f 30 d; e.g., myelo-monocytic cells, which may produce factors affecting N K cell differentiation (39) are present only at early times, and any cell only partially differentiated by the time these changes occur may be unable to mature completely.
The distinctive marker of the immature N K cell subset reported here is N K R -P 1 A . This is a type II integral m e mbrane protein with a region of sequence h o m o l o g y with C-type lectlns in its extracellular domain (21) and 47% homology with rodent NK1L-P1, shown to transduce activatory signals (40) and capable of binding specific carbohydrate moieties (41, 42) . The role and the natural ligand(s) of this molecule, and its biological significance on human N K and T cells is still to be defined, but its usefulness as a marker of N K cell development is clear. N K t L -P 1 A expression on N K cells differentiated from immature progenitor cells has not been analyzed in previous reports, and it remains to be established whether the subset identified here The N K 1 L -P I A + / C D 5 6 -cells are not cytotoxic. The possibility that their functional incompetence is only apparent, and limited to the target cells used, cannot be excluded. However, the observation that after secondary culture these cells can kill the same targets suggests that this is not the case. The inability of these cells to kill is unlikely to depend, primarily, on lack of cytotoxic granule-associated proteins because TIA-1 and perforin were present in a significant percentage of the cells, and SE-1 was functionally active both in total cell lysates and at the single cell level (not shown). Also, surface adhesion molecules known to be involved in target cell recognition (the L F A -1 / C D 1 8 complex) (43, 44) are expressed on the N K R P I A + / C D 5 6 -cells at a density similar to that on the CD56 + cells (data not shown). These data support the hypothesis that lack o f cytotoxiclty depends on the absence of one or more functional cytotoxicity-triggering elements in the C D 5 6 -cells: these may include target recognition receptor(s) yet to be identified a n d / o r biochemical pathways o f signal transduction. Irrespective of the reason, our data indicate that expression of cytotoxic granule-associated proteins precedes functional maturation of the machinery needed for target cell recognition andtriggering of cytotoxicity. This con- *In pnmary cultures, Lm-cells were cultured (2 × 10 s cells/well) on S14hSCF 22° feeder cells with rlL-2 (50 U/ml). The CD3 /NKR-P1A + cell subsets, purified from 30-d cultures, were mcubated, separately, with 30-Gy Irradiated Daudl cells to which rlL-2 (50 U/ml) and rlL-12 (1 ng/ml) were added on days 0, 4, and 7 *IFN-y and TNF-oe were detected by ILIA in the cell-free supernatants collected on the days indicated, n, number of experiments performed.
Based on the data in the murine system (45), however, we consider this unlikely. Whether the B lymphoblastoid feeder cells are necessary (possibly providing cell-cell contact or cytokines), or IL-12 is sufficient in the absence of IL-2 and/or feeder cells, and whether the effect is mediated by this cytokine directly, or indirectly via induced production of additional factors, is under investigation. In IL-12 p40 knockout mice (46) the absolute number and subset composition of NK cells have not been analyzed; however, only a modest, though significant, decrease in spontaneous cytotoxicity has been reported. On this basis we consider it likely that, even if proven sufficient to support late NK cell differentiation, IL-12 is not the sole cytokine able to mediate this effect. One likely candidate for this is IL-15, that induces NK cell differentiation from CD34 + cells (11) and, in the culture conditions reported here, can induce generation, from Lin-cells, of NK cells that are phenotypically more differentiated than those induced by IL-2 (Zamai, L., E. Rosati, I.M. Bennett, and B. Perussla, manuscript in preparation). IL-12 induces myeloid cell differentiation acting with SCF, IL-3, or GM-CSF (47, 48) . Unlike IL-2 and IL-15 (11), IL-12 does not support NK cell differentiation when used instead of IL-2 under identical primary culture conditions (48) : thus, the effects of IL-12 on NK cell differentiation appear to be stage-specific. Whether or not IL-15 has similar effect on the NKR-P1A+/CD56 -immature NK cells is under investigation. Mature NK cells produce several cytokines including IFN-3, and TNF-cl (49, and reviewed in reference 50). The NKlL-P1A+/CD56 -cells, like the CD56+/CD16 -cell subset described by Nagler et al. (34) , express TNF-ci but not IFN-y mlLNA after primary culture. TNF-cl expression is unlikely to reflect myeloid cells contamination because MSE mlkNA was not detectable in the same conditions, and cells with myeloid phenotype were absent. The presence of TNF-ot mRNA in both the CD56 + and the CD56-NKtL-PIA + cell subsets suggests that expression of this cytokine occurs early during NK cell maturation, whereas IFN-y production represents a more specialized function, acquired only at later differentiation stages. The possible biological significance of this remains to be determined.
Based on these observations, it may be speculated that at the onset of an immune response to intracellular pathogens IL-12 plays a role to activate maximally the nonadaptive system of defense, in which NK cell are potent and essential effectors, both enhancing the functional activity of mature NK cells, and inducing maturation of circulating precytotoxic NK cells.
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